The effect of prehospital telecardiology on the mortality and morbidity of ST-segment elevated myocardial infarction patients undergoing primary percutaneous coronary intervention: A cross-sectional study

Autor: Peyman Saberian, Nader Tavakoli, Parisa Hasani-Sharamin, Seyed Hashem Sezavar, Fatemeh Dadashi, Elnaz Vahidi

Publikováno v: Turkish Journal of Emergency Medicine, Vol 20, Iss 1, Pp 28-34 (2020)

OBJECTIVES: The sooner the primary percutaneous coronary intervention (PPCI) is performed, the better prognosis is expected in patients with acute myocardial infarction. The objective is to evaluate the effect of prehospital triage based on electroca

Externí odkaz: https://doaj.org/article/962d416b48aa45d8b3c0368783ecc491

Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial

Autor: Azita H. Talasaz, Parham Sadeghipour, Hooman Bakhshandeh, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somaye Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Mohsen Farrokhpour, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ouria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hamid Rahmani, Seyed Hossein Hosseini, Seyed Masoud Mousavian, Homa Abri, Pardis Sadeghipour, Elahe Baghizadeh, Farnaz Rafiee, Sepehr Jamalkhani, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mahshid Soleimanzadeh, Maryam Aghakouchakzadeh, Vahid Eslami, Pooya Payandemehr, Hossein Khalili, Hamed Talakoob, Taranom Tojari, Shadi Shafaghi, Sanaz Tabrizi, Hessam Kakavand, Alireza Kashefizadeh, Atabak Najafi, David Jimenez, Aakriti Gupta, Mahesh V. Madhavan, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monreal, Naser Hadavand, Alireza Hajighasemi, Khalil Ansarin, Majid Maleki, Saeed Sadeghian, Stefano Barco, Bob Siegerink, Erica S. Spatz, Gregory Piazza, Ajay J. Kirtane, Benjamin W. Van Tassell, Gregory Y. H. Lip, Frederikus A. Klok, Samuel Z. Goldhaber, Gregg W. Stone, Harlan M. Krumholz, Behnood Bikdeli

Publikováno v: Talasaz, A H, Sadeghipour, P, Bakhshandeh, H, Sharif-Kashani, B, Rashidi, F, Beigmohammadi, M T, Moghadam, K G, Rezaian, S, Dabbagh, A, Sezavar, S H, Farrokhpour, M, Abedini, A, Aliannejad, R, Riahi, T, Yadollahzadeh, M, Lookzadeh, S, Rezaeifar, P, Matin, S, Tahamtan, O, Mohammadi, K, Zoghi, E, Rahmani, H, Hosseini, S H, Mousavian, S M, Abri, H, Sadeghipour, P, Baghizadeh, E, Rafiee, F, Jamalkhani, S, Amin, A, Mohebbi, B, Parhizgar, S E, Soleimanzadeh, M, Aghakouchakzadeh, M, Eslami, V, Payandemehr, P, Khalili, H, Talakoob, H, Tojari, T, Shafaghi, S, Tabrizi, S, Kakavand, H, Kashefizadeh, A, Najafi, A, Jimenez, D, Gupta, A, Madhavan, M V, Sethi, S S, Parikh, S A, Monreal, M, Hadavand, N, Hajighasemi, A, Ansarin, K, Maleki, M, Sadeghian, S, Barco, S, Siegerink, B, Spatz, E S, Piazza, G, Kirtane, A J, Tassell, B W V, Lip, G Y H, Klok, F A, Goldhaber, S Z, Stone, G W, Krumholz, H M & Bikdeli, B 2023, ' Atorvastatin versus Placebo in ICU Patients with COVID-19 : Ninety-day Results of the INSPIRATION-S Trial ', Thrombosis and Haemostasis, vol. 123, no. 7, pp. 723-733 . https://doi.org/10.1055/a-2059-4844

Background In the INSPIRATION-S trial, atorvastatin versus placebo was associated with a nonsignificant 16% reduction in 30-day composite of venous/arterial thrombosis or death in intensive care unit (ICU) patients with COVID-19. Thrombo-inflammatory

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6859407a208bfb41a09e412609ae4f85
https://doi.org/10.1055/a-2059-4844

Anthropometric and Biochemical Measures in Bariatric Surgery Candidates: What Is the Role of Inflammatory Potential of Diet?

Autor: Reyhaneh Yousefi, Hashem Sezavar, Mehrnaz Abbasi, Saeed Safari, Azadeh Mottaghi

Publikováno v: Obesity Surgery. 31:3097-3108

The present study aimed to assess dietary total antioxidant capacity (TAC), dietary phytochemical intake (PI), and dietary inflammatory index (DII) in patients with morbid obesity who are candidates of bariatric surgery and their association with ant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e423fc7afca16e0ddbce9bd249b65170
https://doi.org/10.1007/s11695-021-05345-6

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit:90-Day Results from the INSPIRATION Randomized Trial

Autor: Samuel Z. Goldhaber, Naser Hadavand, Aakriti Gupta, Ajay J. Kirtane, Samira Matin, Seyed Ehsan Parhizgar, Gregory Piazza, Mahesh V. Madhavan, Babak Sharif-Kashani, Benjamin W. Van Tassell, Sahil A. Parikh, Parisa Rezaeifar, Vahid Eslami, Homa Abri, Sanaz Hariri Tabrizi, Mohammad Taghi Beigmohammadi, Atabak Najafi, Paul P. Dobesh, Seyed Hossein Hosseini, Farid Rashidi, Hossein Khalili, Bahram Mohebbi, Ali Dabbagh, Manuel Monreal, Behnood Bikdeli, Hooman Bakhshandeh, Elnaz Zoghi, Rasoul Aliannejad, Majid Maleki, Farnaz Rafiee, Atefeh Abedini, Gregory Y.H. Lip, Samrand Fattah Ghazi, Keivan Gohari Moghadam, Pooya Payandemehr, Shadi Shafaghi, Seyed Masoud Mousavian, Alireza Kashefizadeh, Mahdi Yadollahzadeh, Mohsen Farrokhpour, Shaghayegh Shahmirzaei, Ouria Tahamtan, Sepehr Jamalkhani, Gregg W. Stone, Parham Sadeghipour, Azita Hajhossein Talasaz, Alireza Hajighasemi, David Jiménez, Harlan M. Krumholz, Hamid Reza Rahmani, Sanjum S. Sethi, Ahmad Amin, Hessam Kakavand, Somayeh Lookzadeh, Pardis Sadeghipour, Elahe Baghizadeh, Saeed Sadeghian, Seyed Hashem Sezavar, Taghi Riahi, Keyhan Mohammadi

Publikováno v: Bikdeli, B, Talasaz, A H, Rashidi, F, Bakhshandeh, H, Rafiee, F, Rezaeifar, P, Baghizadeh, E, Matin, S, Jamalkhani, S, Tahamtan, O, Sharif-Kashani, B, Beigmohammadi, M T, Farrokhpour, M, Sezavar, S H, Payandemehr, P, Dabbagh, A, Moghadam, K G, Khalili, H, Yadollahzadeh, M, Riahi, T, Abedini, A, Lookzadeh, S, Rahmani, H, Zoghi, E, Mohammadi, K, Sadeghipour, P, Abri, H, Tabrizi, S, Mousavian, S M, Shahmirzaei, S, Amin, A, Mohebbi, B, Parhizgar, S E, Aliannejad, R, Eslami, V, Kashefizadeh, A, Dobesh, P P, Kakavand, H, Hosseini, S H, Shafaghi, S, Ghazi, S F, Najafi, A, Jimenez, D, Gupta, A, Madhavan, M V, Sethi, S S, Parikh, S A, Monreal, M, Hadavand, N, Hajighasemi, A, Maleki, M, Sadeghian, S, Piazza, G, Kirtane, A J, Van Tassell, B W, Stone, G W, Lip, G Y H, Krumholz, H M, Goldhaber, S Z & Sadeghipour, P 2022, ' Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit : 90-Day Results from the INSPIRATION Randomized Trial ', Thrombosis and Haemostasis, vol. 122, no. 1, pp. 131-141 . https://doi.org/10.1055/a-1485-2372
Thrombosis And Haemostasis
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background Thrombotic complications are considered among the main extrapulmonary manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration of prophylactic antithrombotic therapy in these patients remain unknown. Methods Thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5e2e13e348ec82f749b945eb68309d
https://vbn.aau.dk/da/publications/c9500d65-d410-4abc-9a95-21ac6f2607ef

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality among Patients with COVID-19 Admitted to the Intensive Care Unit:The INSPIRATION Randomized Clinical Trial

Autor: Bahram Mohebbi, Rasoul Aliannejad, Farnaz Rafiee, Gregory Y.H. Lip, Alireza Kashefizadeh, Somayeh Lookzadeh, Pooya Payandemehr, Taghi Riahi, Samira Matin, Shaghayegh Shahmirzaei, Manuel Monreal, Benjamin W. Van Tassell, Inspiration Investigators, Gregg W. Stone, Aakriti Gupta, Vahid Eslami, Babak Sharif-Kashani, Seyed Hashem Sezavar, Parisa Rezaeifar, Samuel Z. Goldhaber, Hossein Khalili, Hooman Bakhshandeh, Elnaz Zoghi, Sanaz Hariri Tabrizi, Homa Abri, Paul P. Dobesh, Farid Rashidi, Keivan Gohari Moghadam, Pardis Sadeghipour, Hamid Reza Rahmani, Ajay J. Kirtane, Seyed Hossein Hosseini, Sanjum S. Sethi, Ali Dabbagh, Ahmad Amin, Hessam Kakavand, Harlan M. Krumholz, Seyed Masoud Mousavian, Saeed Sadeghian, David Jiménez, Keyhan Mohammadi, Shadi Shafaghi, Sahil A. Parikh, Gregory Piazza, Mahesh V. Madhavan, Ouria Tahamtan, Alireza Hajighasemi, Majid Maleki, Atefeh Abedini, Mohsen Farrokhpour, Atabak Najafi, Seyed Ehsan Parhizgar, Behnood Bikdeli, Mahdi Yadollahzadeh, Sepehr Jamalkhani, Parham Sadeghipour, Azita Hajhossein Talasaz, Elahe Baghizadeh, Naser Hadavand, Samrand Fattah Ghazi, Mohammad Taghi Beigmohammadi

Publikováno v: Lip, G Y H & INSPIRATION Investigators 2021, ' Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality among Patients with COVID-19 Admitted to the Intensive Care Unit : The INSPIRATION Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 325, no. 16, pp. 1620-1630 . https://doi.org/10.1001/jama.2021.4152

Importance: Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic prophylaxis. Objective: To evaluate the effects of intermediate-dose vs standard-dose prophylact

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d759ab898d7671724f0ab2800ab89fc1
https://vbn.aau.dk/da/publications/b1b63d25-56b1-4049-9aa0-b363dace1134